Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy
Open Access
- 28 November 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-8
Abstract
Group B Streptococcus (GBS) recto-vaginal colonisation in pregnant women is the major risk factor for early-onset invasive GBS disease in their newborns. We aimed to determine the association between serum antibody levels against 11 GBS surface proteins and recto-vaginal acquisition of GBS colonisation during pregnancy. Sera collected from pregnant women at 20–25 weeks and ≥37 weeks of gestation age were measured for IgG titres against GBS surface proteins using a multiplex immunoassay. Women were evaluated for recto-vaginal colonisation every 4–5 weeks. We observed that the likelihood of becoming colonised with GBS during pregnancy was lower in women with IgG titres ≥200 U/mL against gbs0233 (adjusted OR = 0.47 [95% CI: 0.25–0.89], p = 0.021) and ≥85 U/mL for gbs1539 (adjusted OR = 0.44 [95% CI: 0.24–0.82], p = 0.01) when comparing between women who acquired GBS colonisation and those that remained free of GBS colonisation throughout pregnancy. IgG titres (U/mL) specific to BibA and Sip were higher in pregnant women colonised with GBS (380.19 and 223.87, respectively) compared to women with negative GBS cultures (234.42 and 186.21, respectively; p < 0.01) at ≥37 weeks gestation. Antibodies induced by gbs0233 and gbs1539 were associated with a reduced likelihood of recto-vaginal GBS acquisition during pregnancy and warrant further investigation as vaccine targets.Keywords
This publication has 40 references indexed in Scilit:
- An overview of global GBS epidemiologyVaccine, 2013
- Capsular Switching in Group B Streptococcus CC17 Hypervirulent Clone: A Future Challenge for Polysaccharide Vaccine DevelopmentThe Journal of Infectious Diseases, 2012
- Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccinesVaccine, 2012
- Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn DyadsPLOS ONE, 2011
- Where Do Poor Women in Developing Countries Give Birth? A Multi-Country Analysis of Demographic and Health Survey DataPLOS ONE, 2011
- Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistanceBMC Public Health, 2009
- Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive diseaseVaccine, 2008
- Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babiesVaccine, 2006
- Antibodies to Capsular Polysaccharides of Group BStreptococcusin Pregnant Canadian Women: Relationship to Colonization Status and Infection in the NeonateThe Journal of Infectious Diseases, 2001
- Response to Type III Polysaccharide in Women Whose Infants Have Had Invasive Group B Streptococcal InfectionNew England Journal of Medicine, 1990